Vyant Bio, Inc. (NASDAQ:VYNT) Q3 2022 Earnings Call Transcript
Operator: Thank you for standing by. And welcome to the Vyant Bio's Third Quarter 2022 Earnings Conference Call and Webcast.
Source: insidermonkey.com
Stay updated with breaking news from Jay Roberts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Thank you for standing by. And welcome to the Vyant Bio's Third Quarter 2022 Earnings Conference Call and Webcast.
Widnes 1 Runcorn Linnets 1.
“We’re really excited about it,” Leech said. “It was the culmination of a lot of work. As soon as I started, we hit the ground running. The ownership group — [Owner/CEO] Greg [Penner] particularly — tasked us with, ‘What can we do immediately to enhance t
Reaction Biology has concluded a definitive agreement for the acquisition of the US operations of Vyant Bio subsidiary, vivoPharm.